Details van artikel 310 van 435 gevonden artikelen
WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK
Titel:
WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK
Auteur:
Mainz, J.G. Zagoya, C. Polte, L. Naehrlich, L. Sasse, L. Eickmeier, O. Smaczny, C. Barucha, A. Bechinger, L. Duckstein, F. Eschenhagen, P. Kurzidim, L. Caley, L. Peckham, D. Schwarz, C.
Verschenen in:
Journal of cystic fibrosis
Paginering:
Jaargang 21 () nr. S1 pagina's S3
Jaar:
2022
Inhoud:
Uitgever:
European Cystic Fibrosis Society. All rights reserved
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 310 van 435 gevonden artikelen